日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression

Prdm5 抑制 Apc(Min) 驱动的肠腺瘤并调节单酰甘油脂肪酶的表达

G G Galli, H A Multhaupt, M Carrara, K H de Lichtenberg, I B J Christensen, D Linnemann, E Santoni-Rugiu, R A Calogero, A H Lund

Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial

RRM1 蛋白表达对随机分配参加 III 期化疗试验的 NSCLC 患者中长春瑞滨疗效的预测影响

A C Vilmar, E Santoni-Rugiu, J B Sorensen

RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC

RT-PCR 与免疫组织化学法对 NSCLC 中 ERCC1、BRCA1、TUBB3 和 RRM1 的相关性和量化

A Vilmar, J Garcia-Foncillas, M Huarriz, E Santoni-Rugiu, J B Sorensen

Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway

Myc活性参与与pRb/E2F通路平行的G(1)/S促进机制

E Santoni-Rugiu, J Falck, N Mailand, J Bartek, J Lukas